During the last three months, 17 analysts shared their evaluations of Texas Instruments TXN, revealing diverse outlooks from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 4 | 10 | 0 | 1 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 2 | 4 | 6 | 0 | 1 |
| 2M Ago | 0 | 0 | 1 | 0 | 0 |
| 3M Ago | 0 | 0 | 2 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $185.24, a high estimate of $225.00, and a low estimate of $157.00. Observing a 6.66% increase, the current average has risen from the previous average price target of $173.67.
Investigating Analyst Ratings: An Elaborate Study
A clear picture of Texas Instruments's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Mark Lipacis | Jefferies | Lowers | Hold | $175.00 | $200.00 |
| Tristan Gerra | Baird | Raises | Neutral | $175.00 | $125.00 |
| Mark Lipacis | Evercore ISI Group | Raises | Outperform | $225.00 | $213.00 |
| Joshua Buchalter | TD Cowen | Raises | Hold | $175.00 | $160.00 |
| Harlan Sur | JP Morgan | Raises | Overweight | $195.00 | $180.00 |
| Cody Acree | Benchmark | Maintains | Buy | $210.00 | - |
| C J Muse | Cantor Fitzgerald | Maintains | Neutral | $180.00 | - |
| Toshiya Hari | Goldman Sachs | Raises | Sell | $157.00 | $137.00 |
| William Stein | Truist Securities | Raises | Hold | $167.00 | $165.00 |
| Christopher Rolland | Susquehanna | Raises | Positive | $205.00 | $200.00 |
| Tore Svanberg | Stifel | Raises | Hold | $172.00 | $160.00 |
| Hans Mosesmann | Rosenblatt | Maintains | Buy | $210.00 | $210.00 |
| Vijay Rakesh | Mizuho | Raises | Neutral | $170.00 | $164.00 |
| Mark Lipacis | Evercore ISI Group | Announces | Outperform | $213.00 | - |
| C J Muse | Cantor Fitzgerald | Raises | Neutral | $180.00 | $170.00 |
| C J Muse | Cantor Fitzgerald | Maintains | Neutral | $170.00 | - |
| C J Muse | Cantor Fitzgerald | Maintains | Neutral | $170.00 | - |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Texas Instruments. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Texas Instruments compared to the broader market.
- Price Targets: Analysts predict movements in price targets, offering estimates for Texas Instruments's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Texas Instruments's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on Texas Instruments analyst ratings.
About Texas Instruments
Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.
Texas Instruments: A Financial Overview
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Challenges: Texas Instruments's revenue growth over 3 months faced difficulties. As of 31 March, 2024, the company experienced a decline of approximately -16.4%. This indicates a decrease in top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Texas Instruments's net margin excels beyond industry benchmarks, reaching 30.18%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 6.52%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Texas Instruments's ROA stands out, surpassing industry averages. With an impressive ROA of 3.29%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Texas Instruments's debt-to-equity ratio stands notably higher than the industry average, reaching 0.84. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
The Basics of Analyst Ratings
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
